RMD Q4 2022 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$915M+4.4% YoY

Gross Profit

$523M57.1% margin

Operating Income

$255M27.9% margin

Net Income

$195M21.3% margin

EPS (Diluted)

$1.33

QoQ Revenue Growth

+5.8%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

$47M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$5.1B

Total Liabilities

$1.7B

Stockholders' Equity

$3.4B

Cash & Equivalents

$274M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$915M	$876M	+4.4%
Gross Profit	$523M	$491M	+6.5%
Operating Income	$255M	$242M	+5.7%
Net Income	$195M	$195M	-0.0%

Revenue Segments

Sleep And Respiratory

$812M89%

Software As Service

$103M11%